We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.31%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$435M
AUM Growth
-$716M
Cap. Flow
-$763M
Cap. Flow %
-175.1%
Top 10 Hldgs %
44.16%
Holding
647
New
200
Increased
86
Reduced
96
Closed
246

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$28M
2
MTCH icon
Match Group
MTCH
+$22.1M
3
DFNS.U
LGL Systems Acquisition Corp. Units
DFNS.U
+$13.2M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$11.7M
5
ABUS icon
Arbutus Biopharma
ABUS
+$9.21M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$238M
2
AAPL icon
Apple
AAPL
+$158M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$77M
4
FRC
First Republic Bank
FRC
+$42.3M
5
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 16.59%
2 Financials 12.01%
3 Communication Services 5.9%
4 Energy 5.73%
5 Consumer Discretionary 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPE.WS
176
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$244K 0.06%
255,183
-90,600
-26% -$90.2K
CY
177
DELISTED
Cypress Semiconductor
CY
$243K 0.06%
+10,430
New +$238K
ACTTW
178
DELISTED
Act II Global Acquisition Corp Warrant
ACTTW
$242K 0.06%
345,636
+172,748
+100% +$209K
FTACW
179
DELISTED
FinTech Acquisition Corp. III Warrant
FTACW
$240K 0.06%
400,474
+109,775
+38% +$143K
BHF icon
180
Brighthouse Financial
BHF
$3.43B
$239K 0.05%
+9,872
New +$349K
NVST icon
181
CALL
Envista
NVST
$4.55B
$231K 0.05%
+250,000
New +$6.4M
CLVS
182
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$229K 0.05%
+160,200
New +$1.29M
FFIV icon
183
CALL
F5
FFIV
$23.5B
$227K 0.05%
+30,100
New +$3.68M
FMCIU
184
DELISTED
Forum Merger II Corporation Unit
FMCIU
$227K 0.05%
+21,952
New +$239K
HYACU
185
DELISTED
Haymaker Acquisition Corp. II Unit
HYACU
$226K 0.05%
+22,401
New +$238K
FICO icon
186
PUT
Fair Isaac
FICO
$22B
$225K 0.05%
+19,200
New +$7.07M
IOVA icon
187
CALL
Iovance Biotherapeutics
IOVA
$2.89B
$224K 0.05%
94,800
+76,300
+412% +$2.02M
TCO
188
PUT
DELISTED
Taubman Centers Inc.
TCO
$221K 0.05%
+143,500
New +$5.98M
LVOX
189
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$217K 0.05%
22,001
-78,693
-78% -$786K
PFF icon
190
PUT
iShares Preferred and Income Securities ETF
PFF
$13.2B
$215K 0.05%
200,000
-60,000
-23% -$2.15M
IPV.WS
191
DELISTED
InterPrivate Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for shares of com
IPV.WS
$214K 0.05%
+339,048
New +$237K
ZLAB icon
192
CALL
Zai Lab
ZLAB
$2.91B
$210K 0.05%
+17,500
New +$912K
TEVA icon
193
CALL
Teva Pharmaceuticals
TEVA
$42.3B
$200K 0.05%
+336,500
New +$3.45M
CCX.WS
194
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
$199K 0.05%
120,659
-539,524
-82% -$1.01M
VAR
195
DELISTED
Varian Medical Systems, Inc.
VAR
$199K 0.05%
1,940
+873
+82% +$115K
CHNG
196
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$197K 0.05%
+19,714
New +$276K
MRTX
197
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$195K 0.04%
4,700
-10,000
-68% -$897K
FMCIW
198
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$191K 0.04%
707,929
+360,526
+104% +$166K
BMY.RT
199
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$190K 0.04%
50,000
+18,795
+60% +$61.9K
PTON icon
200
CALL
Peloton Interactive
PTON
$2.44B
$189K 0.04%
132,300
+67,900
+105% +$1.89M
6 7
8
9 10

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2020 Portfolio in Review

As of Q1 2020, Cowen and Company held 647 positions worth $435M, down 62% from $1.15B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company withdrew a net $763M in Q1 2020, closing 246 positions and reducing 96 holdings. Its most notable exit was Apple, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 4.9% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Cowen and Company opened a new position in Match Group worth $19.8M.

  • Cowen and Company's largest Q1 2020 buy was Match Group: 300,000 shares worth $19.8M.
  • Cowen and Company added most to ExxonMobil in Q1 2020, an estimated $28M increase.
  • Cowen and Company's biggest Q1 2020 reduction was Invesco QQQ Trust, cutting an estimated $238M.
  • Cowen and Company fully exited Apple in Q1 2020, selling an estimated $158M.
  • Cowen and Company's ten largest holdings make up 44% of its $435M portfolio in Q1 2020.
  • Cowen and Company opened 200 new positions and closed 246 in Q1 2020.
  • Cowen and Company's portfolio value fell 62% quarter-over-quarter to $435M.

Based on Cowen and Company's 13F filing for Q1 2020, filed 11 May 2020.